Filter By Industry
Filter By Tag

Newsroom

ZoomRx Press releases

1 - 1 of 1 Press Release

Pharmacyclics’ Imbruvica has the potential to be a game changing CLL therapy, a ZoomRx study finds
Mar 18, 2014
Imbruvica’s (ibrutinib) recent FDA approval for chronic lymphocytic leukemia (CLL) will lead to significant changes in how physicians treat CLL, a new market research study by ZoomRx reveals.


ZoomRx RSS Feed